Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer

This study has been completed.
Information provided by:
Bristol-Myers Squibb Identifier:
First received: November 30, 2009
Last updated: April 8, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2005
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)